Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
While numerous other GLP1 receptor agonists have since been developed for the management of diabetes, it wasnt until 2014 that a GLP1 receptor agonist, Saxenda (liraglutide), was approved for obesity (liraglutide had previously been approved for diabetes under the name Victoza)
Call us at (480) 808-8499 for current pricing
While the potential of tripeptides in biomedical applications has been proven significant, challenges such as stability, bioavailability, and immunogenicity need to be addressed
Protein Cell 14:464468
US$ 28.80
US$ 29.43
US$ 28.77
US$ 26.29
US$ 20.13
